Det er blevet antaget, at der er en sammenhæng mellem visceral lipomatose og proteasehæmmere (PI) samt en
A connection between visceral lipomatosis and protease inhibitors (PI) and lipoatrophy and nucleoside reverse transcriptase inhibitors (NRTIs) has been hypothesised.